These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36327166)

  • 1. Canine splenic hemangiosarcoma cells express and activate luteinizing hormone receptors in vitro.
    Zwida KH; Kutzler MA
    Am J Vet Res; 2022 Nov; 83(12):. PubMed ID: 36327166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines.
    Witter LE; Gruber EJ; Lean FZ; Stokol T
    Am J Vet Res; 2017 Jan; 78(1):69-79. PubMed ID: 28029283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
    Adachi M; Hoshino Y; Izumi Y; Takagi S
    J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteinizing Hormone Receptor Expression in Neoplastic Mast Cells Is Increased in Spayed and Neutered Dogs.
    Anne Kutzler M; Moccia V; Zwida K; Verena Löhr C
    J Am Anim Hosp Assoc; 2022 Nov; 58(6):271-276. PubMed ID: 36315865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
    Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO
    Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
    U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
    J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma.
    Sorenmo K; Samluk M; Clifford C; Baez J; Barrett JS; Poppenga R; Overley B; Skorupski K; Oberthaler K; Van Winkle T; Seiler G; Shofer F
    J Vet Intern Med; 2007; 21(6):1347-54. PubMed ID: 18196746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.
    Kahn SA; Mullin CM; de Lorimier LP; Burgess KE; Risbon RE; Fred RM; Drobatz K; Clifford CA
    Can Vet J; 2013 Mar; 54(3):237-42. PubMed ID: 23997259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
    Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S
    J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of endothelin inhibitors in canine hemangiosarcoma.
    Fukumoto S; Saida K; Sakai H; Ueno H; Iwano H; Uchide T
    Life Sci; 2016 Aug; 159():55-60. PubMed ID: 26835989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma.
    Musser ML; Coto GM; Lingnan Y; Mochel JP; Johannes CM
    PLoS One; 2022; 17(12):e0279594. PubMed ID: 36548371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
    Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
    Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
    BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperferritinemia in dogs with splenic hemangiosarcoma.
    Chikazawa S; Hori Y; Hoshi F; Kanai K; Ito N; Higuchi S
    J Vet Med Sci; 2013 Nov; 75(11):1515-8. PubMed ID: 23803459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant treatment of canine splenic hemangiosarcoma with autologous dendritic cell therapy - a prospective, randomized double-blind study].
    Reck A; Gedon J; Kessler M
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2023 Dec; 51(6):394-402. PubMed ID: 38056478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma.
    Estabrooks T; Gurinovich A; Pietruska J; Lewis B; Harvey G; Post G; Lambert L; Miller A; Rodrigues L; White ME; Lopes C; London CA; Megquier K
    Vet Comp Oncol; 2023 Dec; 21(4):623-633. PubMed ID: 37734854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma.
    Gedney A; Salah P; Mahoney JA; Krick E; Martins R; Scavello H; Lenz JA; Atherton MJ
    Vet Comp Oncol; 2022 Sep; 20(3):688-696. PubMed ID: 35442554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages.
    Gulay KCM; Aoshima K; Maekawa N; Suzuki T; Konnai S; Kobayashi A; Kimura T
    Sci Rep; 2022 Feb; 12(1):2124. PubMed ID: 35136176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014).
    Batschinski K; Nobre A; Vargas-Mendez E; Tedardi MV; Cirillo J; Cestari G; Ubukata R; Dagli MLZ
    Can Vet J; 2018 Sep; 59(9):967-972. PubMed ID: 30197439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.
    Grimes JA; Prasad N; Levy S; Cattley R; Lindley S; Boothe HW; Henderson RA; Smith BF
    BMC Vet Res; 2016 Dec; 12(1):272. PubMed ID: 27912752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.